001     21624
005     20250112175148.0
022 _ _ |a 1750-9378
|l 1750-9378
024 7 _ |2 ZDBID
|a PERI:(DE-600)2251117-9
024 7 _ |2 ZDBPPN
|a ZDPPN:981256392
024 7 _ |2 EZBID
|a PERI:(DE-606)81998
024 7 _ |2 EZBID
|a PERI:(DE-606)81998
024 7 _ |2 OCLC
|a OCLC:863075373
024 7 _ |2 JCR
|a JCR:INFECT AGENTS CANCER
024 7 _ |2 ISI
|a WOS:INFECTIOUS AGENTS AND CANCER
024 7 _ |2 SCOPUS
|a SCOPUS:5700191215
024 7 _ |2 Medline
|a medline:101276559
035 _ _ |a PERI:(DE-600)2251117-9
040 _ _ |a 8999
|b ger
|c DE-101
|d JOIN²
|e JOIN² journal identification
041 _ _ |a eng
044 _ _ |c XA-GB
082 _ _ |2 22sdnb
|a 610
|q DE-600
082 7 4 |2 22sdnb
|a 610
|q DE-600
210 0 _ |2 DE-600
|a Infect Agent Cancer
210 0 _ |2 dnlm
|a Infect Agent Cancer
210 0 _ |2 iso
|a Infect Agent Cancer
242 2 0 |2 DE-600
|a Infectious agents and cancer
|y en
242 2 0 |2 DE-600
|a Infectious agents and cancer
245 _ _ |2 DE-600
|a Infectious agents and cancer
|h online
246 3 _ |2 DE-600
|a Infectious agents and cancer
246 3 _ |a Infectious agents and cancer
260 _ _ |a London
|b Biomed Central
|c 2006-
260 7 _ |2 DOAJ
|a United Kingdom
|b BMC
|d 2024-04-10T15:40:06Z
|f Infectious Agents and Cancer
264 3 1 |a London
|b Biomed Central
|c 2006-
362 0 _ |2 DE-600
|a 1.2006 -
363 0 1 |2 DE-600
|8 1.1\x
|a 1
|i 2006
365 _ _ |2 DOAJ
|a APC
|b 2290
|c GBP
|d 2024-04-10T15:40:06Z
380 _ _ |2 marcgt
|a journal
500 _ _ |a Automatically generated record. (Updated: 2024-12-12)
650 _ 7 |0 ASJC:1306
|2 ASJC
|a Cancer Research
650 _ 7 |0 ASJC:2725
|2 ASJC
|a Infectious Diseases
650 _ 7 |0 ASJC:2730
|2 ASJC
|a Oncology
650 _ 7 |0 ASJC:2713
|2 ASJC
|a Epidemiology
653 1 0 |2 EZB-Subject
|a Medizin
653 1 0 |2 EZB-Keyword
|a Infektionskrankheiten
653 1 0 |2 EZB-Keyword
|a Onkologie
653 1 0 |2 DOAJ
|a chronic infections
|d 2024-04-10T15:40:06Z
653 1 0 |2 DOAJ
|a infection-associated cancers
|d 2024-04-10T15:40:06Z
653 1 0 |2 DOAJ
|a Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
|d 2024-04-10T15:40:06Z
653 1 0 |2 DOAJ
|a Medicine: Internal medicine: Infectious and parasitic diseases
|d 2024-04-10T15:40:06Z
856 4 _ |d 0
|u http://www.infectagentscancer.com/home
|y Verlag = kostenfrei
856 4 _ |d 0
|u https://ezb.ur.de/?2251117-9
|y EZB
856 4 _ |d 0
|u https://infectagentscancer.biomedcentral.com/about
|y Scope
856 4 _ |d 0
|u https://infectagentscancer.biomedcentral.com/about/editorial-board
|y Editorial board
856 4 _ |d 0
|u https://infectagentscancer.biomedcentral.com/submission-guidelines
|y Instructions for Authors
856 4 _ |d 0
|u https://www.ncbi.nlm.nih.gov/pmc/journals/439
|y Archivierung = kostenfrei
880 1 _ |2 DE-600
|a Infectious agents and cancer
909 C O |o oai:juser.fz-juelich.de:69358
|p authority:PERI
|p authority
909 C O |o oai:juser.fz-juelich.de:69358
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b INFECT AGENTS CANCER : 2022
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
|d 2024-04-10T15:40:06Z
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
|d 2024-04-10T15:40:06Z
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b DOAJ : Anonymous peer review
|d 2024-04-10T15:40:06Z
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0561
|2 StatID
|a Article Processing Charges
|d 2024-12-12
915 _ _ |0 StatID:(DE-HGF)0700
|2 StatID
|a Fees
|d 2024-12-12
980 _ _ |a PERI
980 _ _ |a AUTHORITY


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21